Aymerick Fradin

Aymerick's recent experience includes advising:

• Lhoist Group, a privately held Belgian industrial company and global leader in lime, dolomitic lime, and mineral solutions, on its US$13.5 billion strategic combination of Lhoist North America with Martin Marietta
• Bridgepoint on its €1.6 billion public tender offer for Esker, a key player in the automation of source-to-pay and order-to-cash management cycles
• L’Oréal on the reinforcement of its strategic investment in Galderma Group, a Switzerland-based dermatology company, through the acquisition of an additional 10% stake 
• Worldline on:
  • Its €2.3 billion sale of its Terminals, Solutions & Services (TSS) business line to Apollo Global Management
  • Its €2.3 billion acquisition of SIX Payment Services from SIX in exchange for listed stock
• Calliditas Therapeutics on its acquisition of controlling interest in Genkyotex, a leader in NOX inhibition therapies, followed by a public tender offer
• Valtris Group, a subsidiary of SK Capital Partners, on selling Valtris Champlor’s renewables business to Avril Group
• Groupe Bertrand on its internal reorganization followed by an investment from Goldman Sachs
• Carlyle on selling Forgital Group, a provider of advanced aerospace and industrial forged products, to Stonepeak
• Atos on:
  • Its sale of Worldline shares for €1.2 billion, through a placement to qualified investors by way of ABB and transfer to the Atos UK 2019 Pension Scheme
  • The spinoff of 23.4% of Worldline’s share capital for a total consideration of €2.3 billion
• Ardian on:
  • Selling its majority stake of Kersia, a global leader in biosecurity and food safety, to IK Investment Partners
  • Its €1.73 billion sale of Les Dérivés Résiniques et Terpéniques (DRT), a France-based provider of pine derivative ingredients to Firmenich International
• PSP Investments on its reinvestment in Cerba HealthCare alongside EQT